| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-10128
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-30048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-0016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-12 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-037
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B6-5211 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01T1-161 |
| filingDate |
2016-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2018-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2018524275-A |
| titleOfInvention |
Risk stratification |
| abstract |
The present invention relates to a method of in vivo imaging using meta- [ 123 I] iodobenzylguanidine ([ 123 I] mIBG), and more particularly using said method to define a defined subset of subjects with heart failure. It relates to a method of stratification into a specific treatment plan. [Selection figure] None |
| priorityDate |
2015-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |